Lv11
50 积分 2025-05-13 加入
Safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomised, double-blind, placebo-controlled, parallel-group study
3天前
求助中
Safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomised, double-blind, placebo-controlled, parallel-group study
3天前
已完结
Novel TYK2 inhibitor D-2570 in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase 2 trial
9天前
已完结
Efficacy and safety of chiglitazar add‐on to metformin in type 2 diabetes mellitus ( RECAM study)
10天前
已完结
动脉性肺动脉高压靶向药物治疗医药共管专家共识（2025版）
21天前
已完结
Sotatercept and the Clinical Transformation of Pulmonary Arterial Hypertension
22天前
已完结
Sotatercept for Pulmonary Arterial Hypertension
22天前
已完结
Continued Progress in Therapy for Pulmonary Arterial Hypertension
22天前
已完结
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death
22天前
已完结
Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial
2个月前
已完结
皖公网安备34019202002308
